Table 1. Results of biochemical analysis.
Parameters | C | MTX | MTM | MTME | MTMR | fP |
8-OHdG | 0.81 ±0.03b,c,d | 1.57±0.09a,c,d,e | 2.9±0.28a,b,d,e | 2.10±0.14a,b,c,e | 0.92±0.04b,c,d | 0.001 |
IL-1β | 1.65±0.18b,c,d | 2.81±0.24a,c,d,e | 9.18±0.33a,b,d,e | 4.7±0.42 a,b,c,e | 1.98±0.23b,c,d | 0.001 |
TNF-α | 1.07±0.15b,c,d | 2.16±0.21a,c,d,e | 7.75±0.30a,b,d,e | 4.21±0.27a,b,c,e | 1.63±0.25b,c,d,e | 0.001 |
MDA | 2.65±0.27b,c,d | 3.71±0.54a,c,d,e | 7.98±0.37a,b,d,e | 4.85±0.28a,b,c,e | 3.0±0.31b,c,d | 0.001 |
MPO | 3.20±0.30b,c,d | 6.35±0.56a,c,d,e | 20.33±2.25a,b,d,e | 9.43±0.93a,b,c,e | 3.52±0.54b,c,d | 0.001 |
tGSH | 6.68±0.48b,c,d | 4.21±0.41a,c,e | 1.85±0.18a,b,d,e | 3.73±0.36a,c,e | 6.18±0.45b,c,d | 0.001 |
SOD | 20.0±2.61b,c,d,e | 6.0±0.56a,c,e | 2.88±0.23a,b,d,e | 5.20±0.61a,c,e | 9.95±0.55a,b,c,d | 0.001 |
C: Controls; MTX: Methotrexate group; MTM: Methotrexate+methanol group; MTME: Methotrexate+methanol+ethanol group; MTMR: Methotrexate+methanol+rutin group; 8-OHdG: 8-hydroxy-2 deoxyguanine; IL-1β: Interleukin-1β; TNF-α: Tumor necrosis factor-alpha; MPO: Myeloperoxidase; MDA: Malondialdehyde; tGSH: Glutathione peroxidase; SOD: Superoxide dismutase. aStatistically significantly different when compared with control group; bStatistically significantly different when compared with MTX group; cStatistically significantly different when compared with MTM group; dStatistically significantly different when compared with MTME group; eStatistically significantly different when compared with MTMR group; fP value of ANOVA test.